MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.

Oncogene · 2016 · PMC4603999 · PMID 25867061

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Additionally, we found high FBXO11 level was associated with poor DFS in these 50 patients, although the correlation did not reach statistical significance likely because of small sample size ( Supplementary Figure S3a ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.